EMEA-001931-PIP02-19

Key facts

Active substance
human fibrinogen
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0352/2019
PIP number
EMEA-001931-PIP02-19
Pharmaceutical form(s)
Powder for solution for injection or infusion
Condition(s) / indication(s)
Treatment of acquired fibrinogen deficiency
Route(s) of administration
Intravenous use
Contact for public enquiries
Biotest AG

Tel. + 49 6103 801497
E-mail: andrea.wartenberg-demand@biotest.com

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating